Hyundai Bioscience Co Ltd 048410

Morningstar Rating
₩5,970.00 −200.00 (3.24%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

048410 is trading at a LOCK|N@<F!T premium.
Price
₩6,170.00
Fair Value
LOCK|YV.M$Q@b<NN
Uncertainty
LOCK|yC ^W^^L
1-Star Price
LOCK|&Sz.t#Z%%&
5-Star Price
LOCK|BQ.#K?v$@z
Economic Moat
LOCK|qb
Capital Allocation
—

Trading Information

Previous Close Price
₩6,170.00
Day Range
₩5,930.00–6,420.00
52-Week Range
₩4,565.00–21,500.00
Bid/Ask
₩5,940.00 / ₩5,950.00
Shares Outstanding
96.50M
Market Cap
₩576.12B
Volume/Avg
925,252 / 1M

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
167.89
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Hyundai Bioscience Co Ltd is a Korean biotechnology company. The company is engaged in developing and commercializing bio-fusion technology with the purpose of delivering active ingredients safely and efficiently to the body. It has developed Vitabrid CG, a biomaterial that binds vitamin C with bio-friendly mineral layers, which is a beneficial ingredient in skin brightening, anti-aging, and anti-inflammation; and Vitabrid C12, a premium skincare brand.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Growth
Total Number of Employees
69

Valuation

Metric
048410
Price/Earnings (Normalized)
—
Price/Book Value
5.68
Price/Sales
167.89
Price/Cash Flow
—
Price/Earnings
048410

Financial Strength

Metric
048410
Quick Ratio
2.30
Current Ratio
2.36
Interest Coverage
−14.05
Quick Ratio
048410

Profitability

Metric
048410
Return on Assets (Normalized)
−20.02%
Return on Equity (Normalized)
−23.55%
Return on Invested Capital (Normalized)
−20.06%
Return on Assets
048410

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Vertex Pharmaceuticals Inc
VRTX
LOCK|@H^hh!lLOCK|#<x#?$136B
Regeneron Pharmaceuticals Inc
REGN
LOCK|%fZ%%dLOCK|^th?$99B
Moderna Inc
MRNA
LOCK|!g>zS^LOCK|>bR$87B
argenx SE ADR
ARGX
LOCK|K<?>h%LLOCK|Sn$61B
BeOne Medicines Ltd ADR
ONC
LOCK|%&J&!XLOCK|&w$48B
Royalty Pharma PLC Class A
RPRX
LOCK|@r!&!QBjLOCK|QHPsV$31B
Incyte Corp
INCY
LOCK|Z!wC!^LOCK|f<$25B
Alnylam Pharmaceuticals Inc
ALNY
LOCK|$TvcK@@LOCK|<?h?$$21B
BioNTech SE ADR
BNTX
LOCK|Q$#$T#GLOCK|@?M$21B
Jazz Pharmaceuticals PLC
JAZZ
LOCK|Xx^&$^jLOCK|>s$15B

Sponsor Center